Back to Search
Start Over
Curcumin attenuates prostatic hyperplasia caused by inflammation via up-regulation of bone morphogenetic protein and activin membrane-bound inhibitor.
- Source :
-
Pharmaceutical biology [Pharm Biol] 2021 Dec; Vol. 59 (1), pp. 1026-1035. - Publication Year :
- 2021
-
Abstract
- Context: Inflammation and epithelial-mesenchymal transition (EMT) play important roles in the occurrence and development of benign prostatic hyperplasia (BPH); curcumin exerts anti-proliferative, anti-inflammatory, and anti-EMT effects.<br />Objective: To explore the anti-inflammatory and anti-EMT mechanisms of curcumin in BPH.<br />Materials and Methods: Ten-week-old male C57BL/6 mice were administered lipopolysaccharide (LPS, 100 µg/kg) in the prostate lobules to establish an inflammatory BPH model (LPS group), and curcumin (120 mg/kg) was administered into the abdominal cavity for 2 weeks (three times a week, curcumin-treated group). A group of healthy mice served as the control group. The expression of Toll-like receptor 4 (TLR4), bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI), EMT markers, inflammatory cytokines, and transforming growth factor β1 (TGF-β1) was detected by PCR and western blotting. TGF-β1 (0.1 ng/mL) and LPS (100 ng/mL) were used to induce EMT in benign prostatic hyperplasia epithelial cells (BPH-1).<br />Results: In vivo , curcumin reduced the size of the prostate, suppressed the expression of vimentin and TLR4, and increased the expression of E-cadherin and BAMBI in the LPS-induced BPH mouse model. Moreover, curcumin decreased the levels of IL-6 and TNF-α by 44.52 and 46.17%, respectively. In vitro , curcumin attenuated cell proliferation, suppressed the expression of vimentin and TLR4, and increased the expression of E-cadherin and BAMBI in BPH-1 cells. Furthermore, BAMBI knockdown reversed the expression of vimentin and E-cadherin induced by curcumin.<br />Discussion and Conclusion: This study demonstrated that curcumin alleviated hyperplasia, EMT, and inflammation in vivo . Furthermore, curcumin suppressed EMT by targeting BAMBI via the TLR4/BAMBI/TGF-β1 signalling pathway in vitro , demonstrating its potential utility in BPH treatment.
- Subjects :
- Animals
Cadherins metabolism
Cell Line
Cytokines drug effects
Epithelial-Mesenchymal Transition drug effects
Humans
Inflammation metabolism
Lipopolysaccharides pharmacology
Male
Mice
Mice, Inbred C57BL
Models, Animal
Prostate drug effects
Prostate pathology
Signal Transduction drug effects
Toll-Like Receptor 4 metabolism
Transforming Growth Factor beta1 metabolism
Up-Regulation
Vimentin metabolism
Bone Morphogenetic Proteins metabolism
Curcumin pharmacology
Membrane Proteins metabolism
Prostatic Hyperplasia drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1744-5116
- Volume :
- 59
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Pharmaceutical biology
- Publication Type :
- Academic Journal
- Accession number :
- 34357837
- Full Text :
- https://doi.org/10.1080/13880209.2021.1953539